50 related articles for article (PubMed ID: 1082545)
1. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
Ramot B; Biniaminov M; Shoham C; Rosenthal E
N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
[TBL] [Abstract][Full Text] [Related]
2. Levamisole Suppresses CD4
Wang J; Liu J; Wang M; Zhao F; Ge M; Liu L; Jiang E; Feng S; Han M; Pei X; Zheng Y
Front Immunol; 2022; 13():907808. PubMed ID: 35911766
[TBL] [Abstract][Full Text] [Related]
3. Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.
Wang M; Li X; Shi J; Shao Y; Ge M; Huang J; Huang Z; Zhang J; Nie N; Zheng Y
Int J Hematol; 2015 Aug; 102(2):149-56. PubMed ID: 26072293
[TBL] [Abstract][Full Text] [Related]
4. The role of iron and iron binding proteins in lymphocyte physiology and pathology.
Kemp JD
J Clin Immunol; 1993 Mar; 13(2):81-92. PubMed ID: 8320312
[TBL] [Abstract][Full Text] [Related]
5. Rosette-increasing factor released by PHA-stimulated mononuclear cells in vitro which augments active E and EA rosette formation.
Kubota M; Yoshida T; Shinomiya K; Mikawa H
Clin Exp Immunol; 1980 Jun; 40(3):602-10. PubMed ID: 7418268
[TBL] [Abstract][Full Text] [Related]
6. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
Bier J; Nicklisch U
Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of immunological parameters in immunotherapy for advanced carcinoma of the digestive tract.
Hanaue H; Yoshizaki S; Kurosawa T
Gastroenterol Jpn; 1983 Aug; 18(4):377-83. PubMed ID: 6628922
[TBL] [Abstract][Full Text] [Related]
8. Restoration by levamisole of immune responses suppressed in tumor-bearing mice.
Shiraishi M; Himeno K; Nomoto K
Cancer Immunol Immunother; 1983; 15(2):121-5. PubMed ID: 6553512
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.
Hersey P; Ho K; Werkmeister J; Abele U
Clin Exp Immunol; 1981 Nov; 46(2):340-9. PubMed ID: 6461457
[TBL] [Abstract][Full Text] [Related]
10. Levamisole-induced lichenoid eruptions.
Kirby JD; Black M; McGibbon D
J R Soc Med; 1980 Mar; 73(3):208-11. PubMed ID: 6453230
[No Abstract] [Full Text] [Related]
11. Suppression of pokeweed mitogen-induced differentiation of human B cells by in vitro levamisole-treated T lymphocytes.
Miyawaki T; Seki H; Moriya N; Nagaoki T; Kubo M; Okuda N; Taniguchi N
Clin Exp Immunol; 1980 Apr; 40(1):161-7. PubMed ID: 6446431
[TBL] [Abstract][Full Text] [Related]
12. Effect of levamisole on experimental paracoccidioidomycosis in the Syrian hamster: immunologic and histopathologic correlation.
Rezkallah-Iwasso MT; Mota NG; Gomes MC; Montenegro MR
Mycopathologia; 1984 Feb; 84(2-3):171-80. PubMed ID: 6425694
[TBL] [Abstract][Full Text] [Related]
13. Effect of levamisole on cytotoxic T-cell-mediated immune resistance to L1210 murine leukemia in hyperimmune mice.
Gomi K; Morimoto M; Kataoka T
Cancer Immunol Immunother; 1984; 17(3):195-9. PubMed ID: 6332672
[TBL] [Abstract][Full Text] [Related]
14. Normal natural killer cell activity in Hodgkin's disease patients in remission.
Douer D; Shaked N; Ramot B
Clin Exp Immunol; 1987 Sep; 69(3):660-7. PubMed ID: 3665188
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte numbers and serum E rosette inhibitory substance.
Salimonu LS
J Clin Pathol; 1986 Feb; 39(2):231-2. PubMed ID: 3485118
[No Abstract] [Full Text] [Related]
16. Tissue ferritin concentration and prognosis in carcinoma of the breast.
Weinstein RE; Bond BH; Silberberg BK; Vaughn CB; Subbaiah P; Pieper DR
Breast Cancer Res Treat; 1989 Dec; 14(3):349-53. PubMed ID: 2611407
[TBL] [Abstract][Full Text] [Related]
17. Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.
Chrisp P; McTavish D
Drugs Aging; 1991; 1(4):317-37. PubMed ID: 1794023
[TBL] [Abstract][Full Text] [Related]
18. A case of linitis plastica of the rectum treated by pelvic exenteration after aggressive immunochemotherapy.
Sato S; Iwasaki K; Torisu M
Surg Today; 1992; 22(2):159-62. PubMed ID: 1498496
[TBL] [Abstract][Full Text] [Related]
19. The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.
Verhaegen H; De Cock W; De Cree J
Clin Exp Immunol; 1977 Aug; 29(2):311-5. PubMed ID: 908176
[TBL] [Abstract][Full Text] [Related]
20. Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.
Moroz C; Lahat N; Biniaminov M; Ramot B
Clin Exp Immunol; 1977 Jul; 29(1):30-5. PubMed ID: 891036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
